{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:57:50Z","timestamp":1771718270109,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR-MUR NextGenerationEU PRIN 2022 cod. 2022Y79PT4"],"award-info":[{"award-number":["PNRR-MUR NextGenerationEU PRIN 2022 cod. 2022Y79PT4"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","award":["Progetto GENOMAeSALUTE, POR Campania FESR2014\/2020; CUP: B41C17000080007"],"award-info":[{"award-number":["Progetto GENOMAeSALUTE, POR Campania FESR2014\/2020; CUP: B41C17000080007"]}],"id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007065","name":"University of Salerno","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92438-2","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:13:32Z","timestamp":1741090412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target"],"prefix":"10.1038","volume":"15","author":[{"given":"Elena","family":"Alexandrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marharyta","family":"Smal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario Nicola","family":"Brancaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Nassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Giurato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"92438_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid, B. M., Permuth, J. B. & Sellers, T. A. Epidemiology of ovarian cancer: A review. Cancer Biology Med. 14, 9\u201332. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0084 (2017).","journal-title":"Cancer Biology Med."},{"key":"92438_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"92438_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/PAT.0b013e32835f2264","volume":"45","author":"D Lim","year":"2013","unstructured":"Lim, D. & Oliva, E. Precursors and pathogenesis of ovarian carcinoma. Pathology 45, 229\u2013242. https:\/\/doi.org\/10.1097\/PAT.0b013e32835f2264 (2013).","journal-title":"Pathology"},{"key":"92438_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell, D. D. et al. Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer. Nat. Rev. Cancer. 15, 668\u2013679. https:\/\/doi.org\/10.1038\/nrc4019 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"92438_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053\u20131064. https:\/\/doi.org\/10.2353\/ajpath.2010.100105 (2010).","journal-title":"Am. J. Pathol."},{"key":"92438_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1101\/gad.343251.120","volume":"34","author":"M Shen","year":"2020","unstructured":"Shen, M. & Kang, Y. Stresses in the metastatic cascade: Molecular mechanisms and therapeutic opportunities. Genes Dev. 34, 1577\u20131598. https:\/\/doi.org\/10.1101\/gad.343251.120 (2020).","journal-title":"Genes Dev."},{"key":"92438_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","volume":"2","author":"M Esposito","year":"2021","unstructured":"Esposito, M., Ganesan, S. & Kang, Y. Emerging strategies for treating metastasis. Nat. cancer. 2, 258\u2013270. https:\/\/doi.org\/10.1038\/s43018-021-00181-0 (2021).","journal-title":"Nat. cancer"},{"key":"92438_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.trecan.2022.08.007","volume":"9","author":"M Shen","year":"2023","unstructured":"Shen, M. & Kang, Y. Cancer fitness genes: Emerging therapeutic targets for metastasis. Trends cancer. 9, 69\u201382. https:\/\/doi.org\/10.1016\/j.trecan.2022.08.007 (2023).","journal-title":"Trends cancer"},{"key":"92438_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","volume":"22","author":"A Katti","year":"2022","unstructured":"Katti, A., Diaz, B. J., Caragine, C. M., Sanjana, N. E. & Dow, L. E. CRISPR in cancer biology and therapy. Nat. Rev. Cancer. 22, 259\u2013279. https:\/\/doi.org\/10.1038\/s41568-022-00441-w (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"92438_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41576-021-00409-w","volume":"23","author":"L Przybyla","year":"2022","unstructured":"Przybyla, L. & Gilbert, L. A. A new era in functional genomics screens. Nat. Rev. Genet. 23, 89\u2013103. https:\/\/doi.org\/10.1038\/s41576-021-00409-w (2022).","journal-title":"Nat. Rev. Genet."},{"key":"92438_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00432-020-03207-9","volume":"146","author":"X Zhou","year":"2020","unstructured":"Zhou, X., Li, R., Jing, R., Zuo, B. & Zheng, Q. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively. J. Cancer Res. Clin. Oncol. 146, 1509\u20131521. https:\/\/doi.org\/10.1007\/s00432-020-03207-9 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"92438_CR12","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s00432-022-04160-5","volume":"149","author":"S Shi","year":"2023","unstructured":"Shi, S. et al. Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis. J. Cancer Res. Clin. Oncol. 149, 3349\u20133360. https:\/\/doi.org\/10.1007\/s00432-022-04160-5 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"92438_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbrc.2021.12.023","volume":"589","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Genome-wide CRISPR\/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis. Biochem. Biophys. Res. Commun. 589, 107\u2013115. https:\/\/doi.org\/10.1016\/j.bbrc.2021.12.023 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"92438_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1568009622666220615154137","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Genome-Wide CRISPR-Cas9 screening and identification of potential genes promoting prostate Cancer growth and metastasis. Curr. Cancer Drug Targets. 23, 71\u201386. https:\/\/doi.org\/10.2174\/1568009622666220615154137 (2022).","journal-title":"Curr. Cancer Drug Targets"},{"key":"92438_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260. https:\/\/doi.org\/10.1016\/j.cell.2015.02.038 (2015).","journal-title":"Cell"},{"key":"92438_CR16","doi-asserted-by":"publisher","unstructured":"Zhang, J. et al. Genome-wide CRISPR\/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. J. Exp. Clin. Cancer Res. 41 https:\/\/doi.org\/10.1186\/s13046-022-02242-3 (2022).","DOI":"10.1186\/s13046-022-02242-3"},{"key":"92438_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-021-21898-7","volume":"12","author":"C Pacini","year":"2021","unstructured":"Pacini, C. et al. Integrated cross-study datasets of genetic dependencies in cancer. Nat. Commun. 12, 1661. https:\/\/doi.org\/10.1038\/s41467-021-21898-7 (2021).","journal-title":"Nat. Commun."},{"key":"92438_CR18","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447\u2013452. https:\/\/doi.org\/10.1093\/nar\/gku1003 (2015).","journal-title":"Nucleic Acids Res."},{"key":"92438_CR19","doi-asserted-by":"publisher","first-page":"43843","DOI":"10.18632\/oncotarget.5983","volume":"6","author":"TZ Tan","year":"2015","unstructured":"Tan, T. Z. et al. CSIOVDB: A microarray gene expression database of epithelial ovarian cancer subtype. Oncotarget 6, 43843\u201343852. https:\/\/doi.org\/10.18632\/oncotarget.5983 (2015).","journal-title":"Oncotarget"},{"key":"92438_CR20","doi-asserted-by":"publisher","first-page":"12645","DOI":"10.1038\/ncomms12645","volume":"7","author":"F Coscia","year":"2016","unstructured":"Coscia, F. et al. Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status. Nat. Commun. 7, 12645. https:\/\/doi.org\/10.1038\/ncomms12645 (2016).","journal-title":"Nat. Commun."},{"key":"92438_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12935-022-02740-6","volume":"22","author":"E Alexandrova","year":"2022","unstructured":"Alexandrova, E. et al. Combinatorial targeting of Menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer. Cancer Cell. Int. 22, 336. https:\/\/doi.org\/10.1186\/s12935-022-02740-6 (2022).","journal-title":"Cancer Cell. Int."},{"key":"92438_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1074\/mcp.RA119.001817","volume":"19","author":"E Alexandrova","year":"2020","unstructured":"Alexandrova, E. et al. Interaction proteomics identifies erbeta association with chromatin repressive complexes to inhibit cholesterol biosynthesis and exert an oncosuppressive role in Triple-negative breast Cancer. Mol. Cell. Proteom. 19, 245\u2013260. https:\/\/doi.org\/10.1074\/mcp.RA119.001817 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"92438_CR23","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/pmic.201400404","volume":"15","author":"C Stellato","year":"2015","unstructured":"Stellato, C. et al. Identification of cytoplasmic proteins interacting with unliganded Estrogen receptor alpha and beta in human breast cancer cells. Proteomics 15, 1801\u20131807. https:\/\/doi.org\/10.1002\/pmic.201400404 (2015).","journal-title":"Proteomics"},{"key":"92438_CR24","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo, A. et al. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 15, e0232565. https:\/\/doi.org\/10.1371\/journal.pone.0232565 (2020).","journal-title":"PLoS One"},{"key":"92438_CR25","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for illumina sequence data. Bioinformatics 30, 2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170 (2014).","journal-title":"Bioinformatics"},{"key":"92438_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"92438_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"92438_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"92438_CR29","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter, W., Sanchez-Cabo, F. & Ricote, M. GOplot: An R package for visually combining expression data with functional analysis. Bioinformatics 31, 2912\u20132914. https:\/\/doi.org\/10.1093\/bioinformatics\/btv300 (2015).","journal-title":"Bioinformatics"},{"key":"92438_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygyno.2016.07.111","volume":"143","author":"J Kanska","year":"2016","unstructured":"Kanska, J., Zakhour, M., Taylor-Harding, B., Karlan, B. Y. & Wiedemeyer, W. R. Cyclin E as a potential therapeutic target in high grade serous ovarian cancer. Gynecol. Oncol. 143, 152\u2013158. https:\/\/doi.org\/10.1016\/j.ygyno.2016.07.111 (2016).","journal-title":"Gynecol. Oncol."},{"key":"92438_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000354434","volume":"32","author":"GO Jeong","year":"2013","unstructured":"Jeong, G. O. et al. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells. Cell. Physiol. Biochem. 32, 253\u2013263. https:\/\/doi.org\/10.1159\/000354434 (2013).","journal-title":"Cell. Physiol. Biochem."},{"key":"92438_CR32","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/cncr.23341","volume":"112","author":"MV Barbolina","year":"2008","unstructured":"Barbolina, M. V., Adley, B. P., Shea, L. D. & Stack, M. S. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 112, 1632\u20131641. https:\/\/doi.org\/10.1002\/cncr.23341 (2008).","journal-title":"Cancer"},{"key":"92438_CR33","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.7150\/thno.57455","volume":"11","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. KAT6A, a novel regulator of beta-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1. Theranostics 11, 6278\u20136292. https:\/\/doi.org\/10.7150\/thno.57455 (2021).","journal-title":"Theranostics"},{"key":"92438_CR34","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41467-021-22708-w","volume":"12","author":"M Bleu","year":"2021","unstructured":"Bleu, M. et al. PAX8 and MECOM are interaction partners driving ovarian cancer. Nat. Commun. 12, 2442. https:\/\/doi.org\/10.1038\/s41467-021-22708-w (2021).","journal-title":"Nat. Commun."},{"key":"92438_CR35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41388-022-02210-3","volume":"41","author":"L Lin","year":"2022","unstructured":"Lin, L. et al. SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer. Oncogene 41, 1767\u20131779. https:\/\/doi.org\/10.1038\/s41388-022-02210-3 (2022).","journal-title":"Oncogene"},{"key":"92438_CR36","doi-asserted-by":"publisher","first-page":"eabm2496","DOI":"10.1126\/scisignal.abm2496","volume":"15","author":"D Chaves-Moreira","year":"2022","unstructured":"Chaves-Moreira, D. et al. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17. Sci. Signal. 15, eabm2496. https:\/\/doi.org\/10.1126\/scisignal.abm2496 (2022).","journal-title":"Sci. Signal."},{"key":"92438_CR37","doi-asserted-by":"publisher","first-page":"1021558","DOI":"10.3389\/fonc.2022.1021558","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma. Front. Oncol. 12, 1021558. https:\/\/doi.org\/10.3389\/fonc.2022.1021558 (2022).","journal-title":"Front. Oncol."},{"key":"92438_CR38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s42003-021-02405-6","volume":"4","author":"CL Cheng","year":"2021","unstructured":"Cheng, C. L. et al. Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer. Commun. Biol. 4, 888. https:\/\/doi.org\/10.1038\/s42003-021-02405-6 (2021).","journal-title":"Commun. Biol."},{"key":"92438_CR39","doi-asserted-by":"publisher","first-page":"766656","DOI":"10.3389\/fonc.2021.766656","volume":"11","author":"M Xia","year":"2021","unstructured":"Xia, M. et al. Transcriptional networks identify BRPF1 as a potential drug target based on inflammatory signature in primary Lower-Grade gliomas. Front. Oncol. 11, 766656. https:\/\/doi.org\/10.3389\/fonc.2021.766656 (2021).","journal-title":"Front. Oncol."},{"key":"92438_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41416-020-0763-4","volume":"122","author":"T Masoodi","year":"2020","unstructured":"Masoodi, T. et al. Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases. Br. J. Cancer. 122, 1219\u20131230. https:\/\/doi.org\/10.1038\/s41416-020-0763-4 (2020).","journal-title":"Br. J. Cancer"},{"key":"92438_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acsmedchemlett.6b00092","volume":"7","author":"P Bamborough","year":"2016","unstructured":"Bamborough, P. et al. GSK6853, a chemical probe for Inhibition of the BRPF1 bromodomain. ACS Med. Chem. Lett. 7, 552\u2013557. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00092 (2016).","journal-title":"ACS Med. Chem. Lett."},{"key":"92438_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sj.cdd.4400597","volume":"7","author":"KM Murphy","year":"2000","unstructured":"Murphy, K. M., Ranganathan, V., Farnsworth, M. L., Kavallaris, M. & Lock, R. B. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell. Death Differ. 7, 102\u2013111. https:\/\/doi.org\/10.1038\/sj.cdd.4400597 (2000).","journal-title":"Cell. Death Differ."},{"key":"92438_CR43","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on Serine 139. J. Biol. Chem. 273, 5858\u20135868. https:\/\/doi.org\/10.1074\/jbc.273.10.5858 (1998).","journal-title":"J. Biol. Chem."},{"key":"92438_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2006.05.023","volume":"23","author":"C Lu","year":"2006","unstructured":"Lu, C. et al. Cell apoptosis: Requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol. Cell. 23, 121\u2013132. https:\/\/doi.org\/10.1016\/j.molcel.2006.05.023 (2006).","journal-title":"Mol. Cell."},{"key":"92438_CR45","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","volume":"275","author":"EP Rogakou","year":"2000","unstructured":"Rogakou, E. P., Nieves-Neira, W., Boon, C., Pommier, Y. & Bonner, W. M. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at Serine 139. J. Biol. Chem. 275, 9390\u20139395. https:\/\/doi.org\/10.1074\/jbc.275.13.9390 (2000).","journal-title":"J. Biol. Chem."},{"key":"92438_CR46","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na, T. Y., Schecterson, L., Mendonsa, A. M. & Gumbiner, B. M. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc. Natl. Acad. Sci. U S A. 117, 5931\u20135937. https:\/\/doi.org\/10.1073\/pnas.1918167117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"92438_CR47","doi-asserted-by":"publisher","first-page":"e21395","DOI":"10.1096\/fj.202002413RR","volume":"35","author":"M Teresa Borrello","year":"2021","unstructured":"Teresa Borrello, M. et al. NUPR1 protects liver from lipotoxic injury by improving the Endoplasmic reticulum stress response. FASEB J. 35, e21395. https:\/\/doi.org\/10.1096\/fj.202002413RR (2021).","journal-title":"FASEB J."},{"key":"92438_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger, J. & Moller, D. E. The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409\u2013435. https:\/\/doi.org\/10.1146\/annurev.med.53.082901.104018 (2002).","journal-title":"Annu. Rev. Med."},{"key":"92438_CR49","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","volume":"35","author":"AR Laury","year":"2011","unstructured":"Laury, A. R. et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am. J. Surg. Pathol. 35, 816\u2013826. https:\/\/doi.org\/10.1097\/PAS.0b013e318216c112 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"92438_CR50","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.3892\/ol.2017.6949","volume":"14","author":"HJ Chai","year":"2017","unstructured":"Chai, H. J. et al. PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer. Oncol. Lett. 14, 5871\u20135875. https:\/\/doi.org\/10.3892\/ol.2017.6949 (2017).","journal-title":"Oncol. Lett."},{"key":"92438_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ygyno.2015.12.018","volume":"140","author":"ET Taube","year":"2016","unstructured":"Taube, E. T. et al. Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma. Gynecol. Oncol. 140, 494\u2013502. https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.018 (2016).","journal-title":"Gynecol. Oncol."},{"key":"92438_CR52","doi-asserted-by":"publisher","first-page":"eabf6123","DOI":"10.1126\/sciadv.abf6123","volume":"7","author":"J Reddy","year":"2021","unstructured":"Reddy, J. et al. Predicting master transcription factors from pan-cancer expression data. Sci. Adv. 7, eabf6123. https:\/\/doi.org\/10.1126\/sciadv.abf6123 (2021).","journal-title":"Sci. Adv."},{"key":"92438_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.11.536378","author":"RA Nameki","year":"2023","unstructured":"Nameki, R. A. et al. Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development. BioRxiv https:\/\/doi.org\/10.1101\/2023.04.11.536378 (2023).","journal-title":"BioRxiv"},{"key":"92438_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/bfgp\/elt007","volume":"12","author":"I Barbieri","year":"2013","unstructured":"Barbieri, I., Cannizzaro, E. & Dawson, M. A. Bromodomains as therapeutic targets in cancer. Brief. Funct. Genom. 12, 219\u2013230. https:\/\/doi.org\/10.1093\/bfgp\/elt007 (2013).","journal-title":"Brief. Funct. Genom."},{"key":"92438_CR55","doi-asserted-by":"publisher","first-page":"1115903","DOI":"10.3389\/fcell.2022.1115903","volume":"10","author":"T Viita","year":"2022","unstructured":"Viita, T. & Cote, J. The MOZ-BRPF1 acetyltransferase complex in epigenetic crosstalk linked to gene regulation, development, and human diseases. Front. Cell. Dev. Biol. 10, 1115903. https:\/\/doi.org\/10.3389\/fcell.2022.1115903 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"92438_CR56","doi-asserted-by":"publisher","unstructured":"Aiello, G. et al. Truncated BRPF1 cooperates with smoothened to promote adult Shh medulloblastoma. Cell Rep. 29, 4036\u20134052 https:\/\/doi.org\/10.1016\/j.celrep.2019.11.046  (2019).","DOI":"10.1016\/j.celrep.2019.11.046"},{"key":"92438_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12185-013-1466-x","volume":"99","author":"H Shima","year":"2014","unstructured":"Shima, H. et al. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. Int. J. Hematol. 99, 21\u201331. https:\/\/doi.org\/10.1007\/s12185-013-1466-x (2014).","journal-title":"Int. J. Hematol."},{"key":"92438_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41420-022-01231-x","volume":"8","author":"G Lin","year":"2022","unstructured":"Lin, G., Huang, T., Zhang, X. & Wang, G. Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis. Cell. Death Discov.. 8, 453. https:\/\/doi.org\/10.1038\/s41420-022-01231-x (2022).","journal-title":"Cell. Death Discov."},{"key":"92438_CR59","doi-asserted-by":"publisher","unstructured":"Sole, C. et al. The urinary transcriptome as a source of biomarkers for prostate Cancer. Cancers (Basel). 12 https:\/\/doi.org\/10.3390\/cancers12020513 (2020).","DOI":"10.3390\/cancers12020513"},{"key":"92438_CR60","doi-asserted-by":"publisher","first-page":"113696","DOI":"10.1016\/j.yexcr.2023.113696","volume":"431","author":"J Ling","year":"2023","unstructured":"Ling, J., Tang, Z., Yang, W., Li, Y. & Dong, X. Pygo2 activates BRPF1 via Pygo2-H3K4me2\/3 interaction to maintain malignant progression in colon cancer. Exp. Cell. Res. 431, 113696. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113696 (2023).","journal-title":"Exp. Cell. Res."},{"key":"92438_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12307-019-00227-z","volume":"12","author":"DR Alberto-Aguilar","year":"2019","unstructured":"Alberto-Aguilar, D. R. et al. Ascites from ovarian cancer induces novel fucosylated proteins. Cancer Microenviron. 12, 181\u2013195. https:\/\/doi.org\/10.1007\/s12307-019-00227-z (2019).","journal-title":"Cancer Microenviron"},{"key":"92438_CR62","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1021\/ml5002932","volume":"5","author":"EH Demont","year":"2014","unstructured":"Demont, E. H. et al. 1,3-dimethyl benzimidazolones are potent, selective inhibitors of the BRPF1 bromodomain. ACS Med. Chem. Lett. 5, 1190\u20131195. https:\/\/doi.org\/10.1021\/ml5002932 (2014).","journal-title":"ACS Med. Chem. Lett."},{"key":"92438_CR63","doi-asserted-by":"publisher","first-page":"599995","DOI":"10.3389\/fonc.2021.599995","volume":"11","author":"Y Tan","year":"2021","unstructured":"Tan, Y. et al. PPAR-alpha modulators as current and potential cancer treatments. Front. Oncol. 11, 599995. https:\/\/doi.org\/10.3389\/fonc.2021.599995 (2021).","journal-title":"Front. Oncol."},{"key":"92438_CR64","doi-asserted-by":"publisher","first-page":"e05097","DOI":"10.1016\/j.heliyon.2020.e05097","volume":"6","author":"CW Chen","year":"2020","unstructured":"Chen, C. W., Buj, R., Dahl, E. S., Leon, K. E. & Aird, K. M. ATM Inhibition synergizes with Fenofibrate in high grade serous ovarian cancer cells. Heliyon 6, e05097. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05097 (2020).","journal-title":"Heliyon"},{"key":"92438_CR65","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1158\/1535-7163.MCT-06-0722","volume":"6","author":"Y Yokoyama","year":"2007","unstructured":"Yokoyama, Y. et al. Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer. Mol. Cancer Ther. 6, 1379\u20131386. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0722 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"92438_CR66","first-page":"833","volume":"18","author":"T Shigeto","year":"2007","unstructured":"Shigeto, T., Yokoyama, Y., Xin, B. & Mizunuma, H. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. Oncol. Rep. 18, 833\u2013840 (2007).","journal-title":"Oncol. Rep."},{"key":"92438_CR67","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bcp.2009.02.002","volume":"77","author":"ER Tuller","year":"2009","unstructured":"Tuller, E. R. et al. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem. Pharmacol. 77, 1480\u20131486. https:\/\/doi.org\/10.1016\/j.bcp.2009.02.002 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"92438_CR68","doi-asserted-by":"publisher","first-page":"35161","DOI":"10.1074\/jbc.M112.367367","volume":"287","author":"J Zhou","year":"2012","unstructured":"Zhou, J. et al. Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) suppresses hypoxia-inducible factor-1alpha (HIF-1alpha) signaling in cancer cells. J. Biol. Chem. 287, 35161\u201335169. https:\/\/doi.org\/10.1074\/jbc.M112.367367 (2012).","journal-title":"J. Biol. Chem."},{"key":"92438_CR69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.humpath.2008.09.019","volume":"40","author":"B Davidson","year":"2009","unstructured":"Davidson, B., Hadar, R., Stavnes, H. T., Trope, C. G. & Reich, R. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Hum. Pathol. 40, 705\u2013713. https:\/\/doi.org\/10.1016\/j.humpath.2008.09.019 (2009).","journal-title":"Hum. Pathol."},{"key":"92438_CR70","doi-asserted-by":"publisher","first-page":"147990","DOI":"10.1016\/j.scitotenv.2021.147990","volume":"790","author":"J Leng","year":"2021","unstructured":"Leng, J. et al. Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPARalpha-dependent PI3K\/Akt\/NF-kappaB pathway. Sci. Total Environ. 790, 147990. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.147990 (2021).","journal-title":"Sci. Total Environ."},{"key":"92438_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbrc.2023.03.051","volume":"657","author":"T Kado","year":"2023","unstructured":"Kado, T. et al. Oleic acid stimulates cell proliferation and BRD4-L-MYC-dependent glucose transporter transcription through PPARalpha activation in ovarian cancer cells. Biochem. Biophys. Res. Commun. 657, 24\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2023.03.051 (2023).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92438-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:13:36Z","timestamp":1741090416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92438-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92438"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92438-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7602"}}